Regeneron announces the 2022 winners of the regeneron prize for creative innovation

Tarrytown, n.y. , july 26, 2022 /prnewswire/ -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced the winners of the 10th annual regeneron prize for creative innovation, a competition designed to recognize excellence and creativity in biomedical research conducted by postdoctoral fellows and graduate students.
REGN Ratings Summary
REGN Quant Ranking